Scottish children with multiple neurodevelopmental conditions experience greater school absenteeism and exclusion, poorer exam attainment and increased unemployment, according to a study published October 13 in the open-access journal PLOS Medicine by Michael Fleming of the University of Glasgow, and colleagues.
Children with neurodevelopmental conditions such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), depression and intellectual disability often experience difficulties at school. Multiple neurodevelopmental conditions commonly coexist, but this phenomenon, known as neurodevelopmental multimorbidity, has received relatively little attention in children compared to adults. To address this gap in knowledge, Fleming and his collaborators investigated the prevalence of neurodevelopmental multimorbidity in Scottish schoolchildren and their educational outcomes compared to their peers. The authors linked together five Scotland-wide health and education databases to identify neurodevelopmental multimorbidity in 766,244, four- to 19-year-old children attending school in Scotland between 2009 and 2013. Study limitations are that 96.2% of the participants
It might seem counterintuitive that Merck KGaA, a German science and technology company with a market value of about $67 billion, would pay attention to a neglected tropical disease called schistosomiasis that mostly affects poor and rural communities.
Similarly, providing financial services to underserved parts of the population might not be the most obvious growth strategy for Bank of Montreal, a Canadian banking and financial-services company with about $740 billion in assets under management as of July 31.
Both companies found that serving local communities—and burnishing their reputations as socially responsible businesses—pays off. These efforts helped land Merck and BMO among the top 100 companies in The Wall Street Journal’s new ranking of the world’s most sustainably managed companies.
The ranking is based on a scoring system that Journal research analysts used to compare more than 5,500 publicly traded companies world-wide in areas including social capital, the environment, human capital
Managing Director & Founder of the Biz Latin Hub Group.
The most significant technological advancements that currently shape our society and economy have emerged from challenging times. The internet, for example — without which our daily life as we know it would be possible — emerged in light of the Cold War, after the United States Advanced Research Projects Agency (ARPA) and MIT scientists invented a method to prevent communications from being affected in the event of an attack.
According to the UN, a report from the Economic Commission for Latin America and the Caribbean found that the Covid-19 pandemic is expected to result in the loss of 8.5 million jobs in Latin America and the Caribbean. It has produced new realities through which life and business have managed to get ahead. Digital technology has proven to be the great ally of humanity, facilitating the adaptation of economies
DriveWealth, LLC, a leader in global digital trading technology, today welcomes Minerva Tantoco to her new position as Chief Technology Officer at DriveWealth. In her new role, Tantoco will be responsible for developing and executing DriveWealth’s technology strategy and innovating on the company’s already industry-leading infrastructure to support the next generation of embedded finance solutions.
Tantoco brings over two decades of executive leadership and management expertise working with start-ups, large enterprises, and government organizations. Her leadership will help advance DriveWealth’s growth strategy and expansion into new products and partnerships. The company is currently scaling its technology team, looking to bring on at least 15 new engineers by end of year, and Tantoco will be an integral part of that growth.
“Our mission to democratize access to U.S. equities across the globe demands consistent investment in technology infrastructure and strategy,” says Bob Cortright, Founder and CEO of DriveWealth. “Minerva’s expertise at
The Nasdaq Composite was the strongest performer, rallying 3.2% in the mid-afternoon.
The Dow was up 1.1%, or 300 points, and the S&P 500 climbed 2%.
All three benchmarks inched closer to record territory once again. The Nasdaq and S&P 500 stand to beat their closing level from early September, the Dow’s last record finish was in pre-pandemic times.
Shares of Apple were among the top performers in both indexes. The tech giant is slated to announce its new iPhone on Tuesday after weeks of pandemic-related delays. Apple stock traded nearly 7% higher.
Meanwhile, shares of Nasdaq-listed software company Twilio rallied more almost 8% after the company announced its intention to buy data start-up Segment for $3.2 billion.
Apple’s iPhone 12 launch with 5G will complete the smartphone equation to make speedier wireless access a reality in the US. And coverage with broader price points will spur upgrades into 2021.
Analysts are expecting the iPhone 12 family–iPhone 12 Mini, iPhone 12, iPhone 12 Pro, and iPhone 12 Pro Max–to all feature 5G. The models are rumored to cover a wide range of price points including the $400 to $700 range where the growth will be.
Now Android devices have been all over 5G, but Apple represents the 46% of the market in the US, according to Counterpoint Research. In addition, 5G devices have typically been reserved for the premium market until recently.
Apple’s iPhone 12 series will ensure the two leading smartphone platforms are 5G equipped. As a result, analysts are betting on another supercycle for the iPhone, or a once in a decade upgrade cycle.
Two studies led by UT Southwestern researchers shed light on the biology and potential vulnerabilities of schistosomes — parasitic flatworms that cause the little-known tropical disease schistosomiasis. The findings, published online today in Science, could change the course of this disease that kills up to 250,000 people a year.
About 240 million people around the world have schistosomiasis — mostly children in Africa, Asia, and South America in populations that represent “the poorest of the poor,” says study leader James J. Collins III, Ph.D., associate professor in UTSW’s department of pharmacology.
Most of those infected survive, but those who die often suffer organ failure or parasite-induced cancer. Symptoms can be serious enough to keep people from living productive lives, Collins says.
The parasite that causes this disease has a complicated life cycle that involves stages in both freshwater snails and mammals. Dwelling in mammalian hosts’ circulatory systems, schistosomes feed
BEDFORD, Mass., Oct. 9, 2020 /PRNewswire/ — SpectraWAVE, Inc., a development-stage medical imaging company focused on improving coronary artery disease (CAD) outcomes with photonics, is pleased to announce that Eman Namati, Ph.D., has been appointed Chief Executive Officer. Dr. Namati brings more than a decade of experience leading the development and launch of highly technical medical imaging products.
Dr. Namati said, “The Board, founders, and team at SpectraWAVE have been an inspiring group to join. They are talented, experienced, and purpose-driven, which will be key as we move towards the launch of our new photonic imaging technology for coronary artery disease. Our flagship technology will define our clinical impact and growth, and we are working hard to bring that solution to the market to help as many patients as possible with coronary artery disease.”
“SpectraWAVE has the opportunity to help millions of patients worldwide,” according to Gregg Stone, MD,
Abby Abraham Joins George Clinical to lead Global Data Science and head India Business
OVERLAND PARK, Kan., Oct. 8, 2020
OVERLAND PARK, Kan., Oct. 8, 2020 /PRNewswire/ — Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization’s Global Data Science team and operations in India.
Abraham, a progressive clinical research professional passionate about altering the existing clinical research execution paradigm by bringing together competent and engaged people, brings George Clinical a deep knowledge of novel technologies and smart data processes. He has more than 20 years of experience in the clinical technology industry working with global CROs including progression through multiple roles within clinical operations and general management.
“I am very pleased and delighted to welcome Abby to George Clinical to head up
The global smartphone display panel market recorded total revenue of $18.6 billion in H1 2020, according to the Strategy Analytics Handset Component Technologies service report, “Smartphone Display Panel Market Share Q2 2020: Revenues Jump 2 Percent, Samsung Display Continues to Lead.”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005167/en/
The report finds that Samsung Display led the smartphone display market with 50 percent revenue share followed by BOE Technology and Tianma Microelectronics in the first half of the year. The smartphone display panel revenues recorded a jump of 3 percent year-over-year in H1 2020 due to the shipment of high-end OLED panels to smartphone customers. The top-three vendors capturedalmost 73 percent revenue share in the global smartphone display panel market in H1 2020.